Navigation Links
Prometheus Laboratories Appoints Chief Executive Officer
Date:9/19/2013

SAN DIEGO, Sept. 19, 2013 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company announced today that Ms. Lisa Miller has been appointed to the position of Chief Executive Officer.

With more than 25 years of experience in the global diagnostic and devices industries, Ms. Miller most recently served as Corporate Vice President at DAKO, an Agilent Technologies Company, headquartered in Copenhagen, Denmark. She was responsible for global operations of their cancer diagnostics business, with $375M in revenue and over 500 employees worldwide. She was also a member of the Board of Directors and Corporate Management Team. Under her leadership, Ms. Miller redefined DAKO's strategy and restructured the commercial operations of the company, resulting in its 2012 acquisition by Agilent Technologies.

Prior to joining DAKO, Ms. Miller was with Invitrogen Corporation, in the position of Vice President, Commercial Business and head of the Americas region. Prior to this, she held several positions of increasing commercial responsibility at Thermo Fisher Scientific, most recently as Vice President Sales with accountability for a $600M business. During her tenure at Thermo Fisher, Ms. Miller held several senior sales and account management positions focused on growth and business development through contractual relationships with major pharmaceutical companies.

Ms. Miller commented: "I am very enthusiastic about joining Prometheus to drive our diagnostic strategy across the chosen therapeutic platforms. I believe Prometheus plays a key role in Nestle Health Science's ambition to create a new segment in health care, using diagnostic and nutrition science solutions in the management of disease."

"We are delighted to have Ms. Miller join our team," commented Cathy Kerzner, interim CEO of Prometheus. "We anticipate she will make a tremendous contribution to our growth strategy, with her depth in diagnostics along with her proven record of performance.'

About Prometheus
Prometheus Laboratories Inc. is committed to improving lives through the development and commercialization of novel pharmaceutical and diagnostic products that enable physicians to provide greater individualized patient care. Prometheus is a leader in applying the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and is applying these principles to oncology. Its strategy includes the marketing and delivery of pharmaceutical products complemented by proprietary diagnostic testing services. By integrating therapeutics and diagnostics, Prometheus believes it can provide physicians with more targeted solutions to optimize care for their patients. Prometheus became part of Nestle Health Science in July 2011. The corporate offices of Prometheus are located in San Diego, California. For more information about Prometheus, please visit www.prometheuslabs.com.

About Nestle Health Science
Nestle Health Science, a wholly-owned subsidiary of Nestle, intends to spearhead the development of science-based personalised nutritional solutions. Building on its core HealthCare Nutrition business, the company has ambitions to address chronic conditions in the area of Gastrointestinal Health, Metabolic Health and Brain Health. Nestle Health Science offers nutritional solutions for people with specific dietary needs related to illnesses, disease states or the special challenges of different life stages. Nestle Health Science employs around 3,000 people worldwide and has its headquarters in Vevey, Switzerland.For more information, please visit www.nestlehealthscience.com.


'/>"/>
SOURCE Prometheus Laboratories Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Data Support Role of Prometheus Laboratories Novel Assay in Optimizing IBD Treatment Management
2. Prometheus Launches New Monitoring Test To Help Guide Inflammatory Bowel Disease Management
3. Prometheus Launches New Adalimumab Drug And Antibody Levels Monitoring Test
4. Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages
5. Millennium Laboratories Sponsors Educational Programs in Support of Safe Prescribing Practices at Regional Pain Society Conferences
6. Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
7. Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation
8. Everett Laboratories, Inc. Files Patent Infringement Lawsuit Against Competitor Trigen Laboratories, Inc.
9. PeaceHealth Laboratories New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
10. Omega Laboratories Applauds the Adoption of Enzyme Immunoassay (EIA) by Major Hair Testing Laboratories
11. Court Preliminarily Deems Millennium Laboratories Press Release Misleading
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 Research ... Pharmacogenomics Market Size, Market Share, Application Analysis, Regional Outlook, Growth ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 ... Mn by 2024, expanding at a CAGR of 5.6% from ...
(Date:4/20/2017)... -- Research and Markets has announced the addition ... Analysis By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, ... report to their offering. ... The Latin American pharmaceutical contract manufacturing services market is ... Low drug registration cost in Latin American countries and continuous ...
(Date:4/19/2017)... , April 19, 2017 The Mobile X-Ray product ... a healthy CAGR during the forecast period Mobile ... the global digital mobile X-Ray devices market, which is estimated ... 2017, expanding at a CAGR of 7% over the forecast ... opportunity of more than US$ 100 Mn in 2017 over ...
Breaking Medicine Technology:
(Date:4/21/2017)... , ... April 21, 2017 , ... ... weeklong campaign, AWARE: A Week of Addiction and Recovery Education, from April 24 ... treating and preventing substance use disorders. , The mission of AWARE is ...
(Date:4/21/2017)... ... April 21, 2017 , ... Northern California Medical Associates ... Spring Symposium on April 1, 2017 in Santa Rosa. This well-attended annual conference ... providers an opportunity to learn about cutting edge treatments, to collaborate, share research ...
(Date:4/21/2017)... ... April 21, 2017 , ... Providing for loved ones before one’s passing is ... where to even begin. “Now more than ever there are some questions that are ... and your family,” said attorney Lisa Edgar Dickman, founder of the Law Offices of ...
(Date:4/21/2017)... , ... April 21, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... leaders in hopes of squashing a global crisis with solution to peace plan. Yisrayl says ... work because the plan is given by the Creator Himself. , Yisrayl says war ...
(Date:4/21/2017)... Texas (PRWEB) , ... April 21, 2017 , ... ... sound familiar? These are five common elements between the Obamacare program that ... hog control program which uses Warfarin poison to kill hogs. , Like ...
Breaking Medicine News(10 mins):